Quantifying crystal form content in physical mixtures of (±)-tartaric acid and (+)-tartaric acid using near infrared reflectance spectroscopy

AAPS PharmSciTech

Volumn 6, Issue 2, 2005, Pages

  Luner, Paul E ^a,b   Patel, Aditya D ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b PFIZER INC   (United States)

^c Helios Pharmaceuticals   (India)

Author keywords

Crystal form; Enantiomers; Near infrared spectroscopy; Quantification; Racemate; Tartaric acid

Indexed keywords

TARTARIC ACID;

ANALYTICAL ERROR; ARTICLE; CALIBRATION; CONTROLLED STUDY; CRYSTALLIZATION; DIFFUSE REFLECTANCE SPECTROSCOPY; ENANTIOMER; NEAR INFRARED REFLECTANCE SPECTROSCOPY; PREDICTION; QUANTITATIVE ANALYSIS; RACEMIC MIXTURE; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SOLID STATE; VALIDATION PROCESS;

EID: 27744527518     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt060235pt060235     Document Type: Article

References (26)

1. Millership JS, Fitzpatrick A. Commonly used chiral drugs: a survey. Chirality. 1993;5:573-576.
2. Drayer DE. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: overview. Clin Pharmacol Ther. 1986;40:125-133.
3. Jacques J, Collet A, Wilen SH. Enantiomers, Racemates and Resolutions. New York, NY: John Wiley & Sons; 1981.
4. Duddu SP, Grant DJ. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates. Pharm Res. 1994;11:1549-1556.
5. Piyarom S, Yonemochi E, Oguchi T, Yamamoto K. Effects of grinding and humidification on the transformation of conglomerate to racemic compound in optically active drugs. J Pharm Pharmacol. 1997;49:384-389.
6. Calatozzolo M, Celentano G, Clerici F, Giammarusti G, Stradi R. FT-IR spectroscopy for the evaluation of the enantiomeric purity of levodropropizine:comparison with HPLC analysis. Boll Chim Pharm. 1993;132:467-471.
7. Phadnis NV, Suryanarayanan R. Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry. Pharm Res. 1997;14:1176-1180.
8. Stahly GP, McKenzie AT, Andres MC, Russell CA, Johnson P. Determination of the optical purity of ibuprofen using X-ray powder diffraction. J Pharm Sci. 1997;86:970-971.
9. 13C-NMR in the presence of chiral lanthanide shift reagent. J Pharm Biomed Anal. 1994:12:295-299.
10. Hanna GM. Determination of enantiomeric composition of ibuprofen in bulk drug by proton nuclear magnetic resonance spectroscopy with a chiral lanthanide chelate. J Pharm Biomed Anal. 1997;15:1805-1811.
11. Hill HDW: Zens AP, Jacobus J. Solid-state NMR spectroscopy, distinction of diastereomers and determination of optical purity. J Am Chem Soc. 1979;101:7090-7091.
12. Elsabee M, Prankerd RJ. Solid-state properties of drugs. Part 3. Differential scanning calorimetry of chiral drug mixtures existing as racemic solid solutions, racemic mixtures or racemic compounds. Int J Pharm. 1992;86:221-230.
13. Buchanan BR, Ciurczak EW, Grunke AQ, Honigs DE. Determination of enantiomeric purity of valine via Near-infrared reflectance spectroscopy. Spectroscopy. 1988;3:54-56.
14. Luner PE, Majuru S, Seyer JJ, Kemper MS. Quantifying crystalline form composition in binary powder mixtures using near-infrared reflectance spectroscopy. Pharm Dev Technol. 2000;5:231-246.
15. Seyer JJ, Luner PE, Kemper MS. Application of diffuse reflectance near-infrared spectroscopy for determination of crystallinity. J Pharm Sci. 2000;89:1305-1316.
16. The United States Pharmacopeia. USP24. Rockville, MD: US Pharmacopeial Convention 2000:2149-2152.
17. Powder Diffraction File. Swarthmore, PA: International Center for Diffraction Data; 1989.
18. Kirsch JD, Drennen JK. Near-infrared spectroscopy: applications in the analysis of tablets and solid pharmaceutical dosage forms. Appl Spectrosc Rev. 1995;30:139-174.
19. Workman JJ, Jr. Interpretive Spectroscopy for Near Infrared. Appl Spectrosc Rev. 1996;31:251-320.
20. Luner PE, Patel AD, Swenson DC. (+/-)-tartaric acid. Acta Crystallogr C. 2002;58:O333-O335.
21. Patel AD, Swenson DC, Luner PE. Solid-state characterization and crystal structure of di-tartaric acid. PharmSci. 2000;2:3587.
22. Patel AD. Solid-state characterization and quantitative analysis of crystal forms using near infrared reflectance spectroscopy [master's thesis]. Iowa City, Iowa: University of Iowa, College of Pharmacy; 2000.
23. Honigs DE. Near infrared analysis. Anal Instrum. 1985;14:1-62.
24. Workman JJ. NIR Calibration In: Burns DA, Ciurczak E, eds. Practical Spectroscopy Series: Handbook of Near-Infrared Analysis. vol. 13. 1st ed. New York: Marcel Dekker Inc: 1992:274-275.
25. Borer MW, Zhou X, Hays DM, Hofer JD, White KC. Evaluation of key sources of variability in the measurement of pharmaceutical drug products by near infrared reflectance spectroscopy. J Pharm Biomed Anal. 1998:17:641-650.
26. Yoon WL, Jee RD, Moffat AC. Optimisation of sample presentation for the near-infrared spectra of pharmaceutical excipients. Analyst. 1998;123:1029-1034.